Chalazan, Brandon

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature

Genetic Associations and EpidemiologyGenomics and Rare Diseases

Cited by 2,213

Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation

Hong, L., Zhang, M., Ly, O. T., Chen, H., Sridhar, A., Lambers, E., Chalazan, B., Youn, S.-W., Maienschein-Cline, M., Feferman, L., et al. (2021) · Stem Cell Reports

Cardiac electrophysiology and arrhythmiasPluripotent Stem Cells Research

Cited by 44

Genetic testing in monogenic early-onset atrial fibrillation

Chalazan, B., Freeth, E., Mohajeri, A., Ramanathan, K., Bennett, M., Walia, J., Halperin, L., Roston, T., Lazarte, J., Hegele, R. A., et al. (2023) · European Journal of Human Genetics

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 23